Qiagen NV
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silic… Read more
Qiagen NV (QGEN) - Total Assets
Latest total assets as of December 2025: $6.30 Billion USD
Based on the latest financial reports, Qiagen NV (QGEN) holds total assets worth $6.30 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Qiagen NV - Total Assets Trend (1995–2025)
This chart illustrates how Qiagen NV’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Qiagen NV - Asset Composition Analysis
Current Asset Composition (December 2025)
Qiagen NV's total assets of $6.30 Billion consist of 31.7% current assets and 68.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.3% |
| Accounts Receivable | $402.61 Million | 6.4% |
| Inventory | $301.89 Million | 4.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $386.43 Million | 6.1% |
| Goodwill | $2.70 Billion | 42.9% |
Asset Composition Trend (1995–2025)
This chart illustrates how Qiagen NV's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Qiagen NV's current assets represent 31.7% of total assets in 2025, a decrease from 66.0% in 1995.
- Cash Position: Cash and equivalents constituted 13.3% of total assets in 2025, down from 20.2% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is goodwill at 42.9% of total assets.
Qiagen NV Competitors by Total Assets
Key competitors of Qiagen NV based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Qiagen NV - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Qiagen NV generates 0.33x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Qiagen NV generates $6.75 in net profit.
Qiagen NV - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.90 | 3.61 | 3.34 |
| Quick Ratio | 3.31 | 3.09 | 2.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.48 Billion | $ 1.42 Billion | $ 1.17 Billion |
Qiagen NV - Advanced Valuation Insights
This section examines the relationship between Qiagen NV's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.35 |
| Latest Market Cap to Assets Ratio | 1.35 |
| Asset Growth Rate (YoY) | 10.7% |
| Total Assets | $6.30 Billion |
| Market Capitalization | $8.48 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Qiagen NV's assets above their book value (1.35 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Qiagen NV's assets grew by 10.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Qiagen NV (1995–2025)
The table below shows the annual total assets of Qiagen NV from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $6.30 Billion | +10.66% |
| 2024-12-31 | $5.69 Billion | -6.96% |
| 2023-12-31 | $6.12 Billion | -2.74% |
| 2022-12-31 | $6.29 Billion | +2.29% |
| 2021-12-31 | $6.15 Billion | +4.72% |
| 2020-12-31 | $5.87 Billion | +12.11% |
| 2019-12-31 | $5.24 Billion | -8.92% |
| 2018-12-31 | $5.75 Billion | +14.09% |
| 2017-12-31 | $5.04 Billion | +16.95% |
| 2016-12-31 | $4.31 Billion | +2.83% |
| 2015-12-31 | $4.19 Billion | -5.94% |
| 2014-12-31 | $4.45 Billion | +8.95% |
| 2013-12-31 | $4.09 Billion | -0.91% |
| 2012-12-31 | $4.13 Billion | +9.84% |
| 2011-12-31 | $3.76 Billion | -4.03% |
| 2010-12-31 | $3.91 Billion | +3.10% |
| 2009-12-31 | $3.80 Billion | +31.58% |
| 2008-12-31 | $2.89 Billion | +3.97% |
| 2007-12-31 | $2.78 Billion | +128.97% |
| 2006-12-31 | $1.21 Billion | +58.37% |
| 2005-12-31 | $765.30 Million | +7.09% |
| 2004-12-31 | $714.60 Million | +29.47% |
| 2003-12-31 | $551.93 Million | +21.43% |
| 2002-12-31 | $454.51 Million | +27.33% |
| 2001-12-31 | $356.97 Million | +55.03% |
| 2000-12-31 | $230.26 Million | +55.46% |
| 1999-12-31 | $148.12 Million | +38.82% |
| 1998-12-31 | $106.70 Million | +35.23% |
| 1997-12-31 | $78.90 Million | +19.18% |
| 1996-12-31 | $66.20 Million | +152.67% |
| 1995-12-31 | $26.20 Million | -- |